Literature DB >> 22586066

Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo.

Andrea Schiefer1, Alexander Schmitz, Till F Schäberle, Sabine Specht, Christine Lämmer, Kelly L Johnston, Dmitry G Vassylyev, Gabriele M König, Achim Hoerauf, Kenneth Pfarr.   

Abstract

Doxycycline and rifampicin deplete essential Wolbachia from filarial nematodes that cause lymphatic filariasis or onchocerciasis, resulting in blocked worm development and death. However, doxycycline is contraindicated for children and pregnant/breastfeeding women, as is rifampicin in the latter group with the additional specter of possible resistance development in Mycobacterium spp. Novel antibiotics with a narrower spectrum would aid in eliminating filarial diseases. Corallococcus coralloides synthesizes corallopyronin A, a noncompetitive inhibitor of RNA polymerase ineffective against Mycobacterium spp. Corallopyronin A depleted Wolbachia from infected insect cells (1.89 Thus the antibiotic is effective against intracellular bacteria despite the many intervening surfaces (blood vessels, pleura, worm cuticle) and membranes (worm cell, vesicle, Wolbachia inner and outer membranes). Corallopyronin A is an antibiotic to develop further for filariasis elimination without concern for cross-resistance development in tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22586066      PMCID: PMC3490692          DOI: 10.1093/infdis/jis341

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis.

Authors:  A Hoerauf; L Volkmann; C Hamelmann; O Adjei; I B Autenrieth; B Fleischer; D W Büttner
Journal:  Lancet       Date:  2000-04-08       Impact factor: 79.321

2.  RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus.

Authors:  A O'Neill; B Oliva; C Storey; A Hoyle; C Fishwick; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.

Authors:  A Hoerauf; S Mand; O Adjei; B Fleischer; D W Büttner
Journal:  Lancet       Date:  2001-05-05       Impact factor: 79.321

Review 4.  Filariasis in Africa--treatment challenges and prospects.

Authors:  A Hoerauf; K Pfarr; S Mand; A Y Debrah; S Specht
Journal:  Clin Microbiol Infect       Date:  2011-07       Impact factor: 8.067

5.  The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales).

Authors:  H Irschik; K Gerth; G Höfle; W Kohl; H Reichenbach
Journal:  J Antibiot (Tokyo)       Date:  1983-12       Impact factor: 2.649

6.  The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort.

Authors:  P Esterre; C Plichart; Y Sechan; N L Nguyen
Journal:  Trop Med Int Health       Date:  2001-03       Impact factor: 2.622

7.  Structural mechanism for rifampicin inhibition of bacterial rna polymerase.

Authors:  E A Campbell; N Korzheva; A Mustaev; K Murakami; S Nair; A Goldfarb; S A Darst
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

8.  Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship.

Authors:  N G Langworthy; A Renz; U Mackenstedt; K Henkle-Dührsen; M B de Bronsvoort; V N Tanya; M J Donnelly; A J Trees
Journal:  Proc Biol Sci       Date:  2000-06-07       Impact factor: 5.349

9.  Transovarially-transmitted intracellular microorganisms in adult and larval stages of Brugia malayi.

Authors:  W J Kozek
Journal:  J Parasitol       Date:  1977-12       Impact factor: 1.276

10.  Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability.

Authors:  Lars Volkmann; Kerstin Fischer; Mark Taylor; Achim Hoerauf
Journal:  Trop Med Int Health       Date:  2003-05       Impact factor: 2.622

View more
  23 in total

1.  Orientia tsutsugamushi Is Highly Susceptible to the RNA Polymerase Switch Region Inhibitor Corallopyronin A In Vitro and In Vivo.

Authors:  Fredericke Kock; Matthias Hauptmann; Anke Osterloh; Till F Schäberle; Sven Poppert; Hagen Frickmann; Klaus-Dieter Menzel; Gundela Peschel; Kenneth Pfarr; Andrea Schiefer; Gabriele M König; Achim Hoerauf; Bernhard Fleischer; Christian Keller
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

2.  Efficacy of three-week oxytetracycline or rifampin monotherapy compared with a combination regimen against the filarial nematode Onchocerca ochengi.

Authors:  Germanus S Bah; Emma L Ward; Abhishek Srivastava; Alexander J Trees; Vincent N Tanya; Benjamin L Makepeace
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

3.  Function of the loading module in CorI and of the O-methyltransferase CorH in vinyl carbamate biosynthesis of the antibiotic corallopyronin A.

Authors:  Till F Schäberle; Mahsa Mir Mohseni; Friederike Lohr; Alexander Schmitz; Gabriele M König
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

4.  Development of patent Litomosoides sigmodontis infections in semi-susceptible C57BL/6 mice in the absence of adaptive immune responses.

Authors:  Laura E Layland; Jesuthas Ajendra; Manuel Ritter; Anna Wiszniewsky; Achim Hoerauf; Marc P Hübner
Journal:  Parasit Vectors       Date:  2015-07-25       Impact factor: 3.876

5.  Integrated transcriptomic and proteomic analysis of the global response of Wolbachia to doxycycline-induced stress.

Authors:  Alistair C Darby; A Christina Gill; Stuart D Armstrong; Catherine S Hartley; Dong Xia; Jonathan M Wastling; Benjamin L Makepeace
Journal:  ISME J       Date:  2013-10-24       Impact factor: 10.302

6.  Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis.

Authors:  Kelly L Johnston; Louise Ford; Indira Umareddy; Simon Townson; Sabine Specht; Kenneth Pfarr; Achim Hoerauf; Ralf Altmeyer; Mark J Taylor
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-09-16       Impact factor: 4.077

7.  Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model.

Authors:  Sabine Specht; Kenneth M Pfarr; Sandra Arriens; Marc P Hübner; Ute Klarmann-Schulz; Marianne Koschel; Sonja Sternberg; Coralie Martin; Louise Ford; Mark J Taylor; Achim Hoerauf
Journal:  PLoS Negl Trop Dis       Date:  2018-01-04

8.  Structural basis of head to head polyketide fusion by CorB.

Authors:  Georg Zocher; Joachim Vilstrup; Daniel Heine; Asis Hallab; Emilie Goralski; Christian Hertweck; Mark Stahl; Till F Schäberle; Thilo Stehle
Journal:  Chem Sci       Date:  2015-08-06       Impact factor: 9.825

9.  AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis.

Authors:  W David Hong; Farid Benayoud; Gemma L Nixon; Louise Ford; Kelly L Johnston; Rachel H Clare; Andrew Cassidy; Darren A N Cook; Amy Siu; Motohiro Shiotani; Peter J H Webborn; Stefan Kavanagh; Ghaith Aljayyoussi; Emma Murphy; Andrew Steven; John Archer; Dominique Struever; Stefan J Frohberger; Alexandra Ehrens; Marc P Hübner; Achim Hoerauf; Adam P Roberts; Alasdair T M Hubbard; Edward W Tate; Remigiusz A Serwa; Suet C Leung; Li Qie; Neil G Berry; Fabian Gusovsky; Janet Hemingway; Joseph D Turner; Mark J Taylor; Stephen A Ward; Paul M O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-07       Impact factor: 11.205

Review 10.  Biosynthesis of α-pyrones.

Authors:  Till F Schäberle
Journal:  Beilstein J Org Chem       Date:  2016-03-24       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.